In more mature patients, This is certainly critical to grasp as polypharmacy is frequent and will potentiate the potential risk of DDIs and ADRs. For that reason, concurrent intake of CYP2D6 inhibitors or inducers could potentiate or block tramadol conversion into ODT and This may boost or lessen efficacy/ADRs https://hemalchem.com/product/o-dsmt/